FDA Approves ELINEST — Northstar Rx LLC

On March 28, 2012, Northstar Rx LLC won FDA approval of its ANDA for the combined oral contraceptive ELINEST (norgestrel and ethinyl estradiol), positioning the manufacturer to compete within a lucrative women's healthcare market. The approval of this brand-name alternative from a solid company like Northstar Rx could impact the competitive landscape, likely pressuring competitors to defend their market share against rising supply chain leverage.